2008
DOI: 10.1097/scs.0b013e31816aaaad
|View full text |Cite
|
Sign up to set email alerts
|

Collagen Scaffolds Implanted in the Palatal Mucosa

Abstract: Scar formation after repair of the cleft palate leads to growth impairment of the upper jaw and midface. The implantation of a suitable scaffold during surgery may reduce this adverse effect. However, little is known about tissue reactions to scaffolds implanted in the oral cavity. Our goal was to analyze the tissue reactions to cross-linked type I collagen scaffolds after submucoperiosteal implantation in the palate of rats. Collagen type I scaffolds were implanted in the palate of 25 male Wistar rats. Groups… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
6
1

Year Published

2010
2010
2021
2021

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 14 publications
(7 citation statements)
references
References 48 publications
(44 reference statements)
0
6
1
Order By: Relevance
“…It has been reported that collagen scaffolds implanted in oral mucoperiosteal defects improve wound healing and reduce contracture and scar tissue formation [3,[14][15][16]. Recently we succeeded in developing a novel scaffold that can provide sustained release of bFGF [17].…”
Section: Introductionmentioning
confidence: 97%
“…It has been reported that collagen scaffolds implanted in oral mucoperiosteal defects improve wound healing and reduce contracture and scar tissue formation [3,[14][15][16]. Recently we succeeded in developing a novel scaffold that can provide sustained release of bFGF [17].…”
Section: Introductionmentioning
confidence: 97%
“…It induces only a mild inflammatory reaction during degradation and has good biodegradable and biocompatible properties. The space occupied by the collagen material is replaced by host soft tissue within 4 to 12 weeks 23,25 . Excessive tension bears a risk of wound dehiscence.…”
Section: Discussionmentioning
confidence: 99%
“…When autologous oral mucosa for grafting is scarce (e.g., large defects), tissue-engineered products can be an alternative tissue source. In fact, epithelial sheets, 15-21 acellular dermal allografts, [22][23][24][25][26][27] oral mucosa equivalents, 4,5,28 bioabsorbable polyglactin meshes, 29,30 collagen-glycosaminoglycan membranes, 31 hyaluronic acid, 32 collagen and silicon bilayer membranes, 33 and collagen scaffolds [34][35] have been preclinically and clinically evaluated. Each of the aforementioned approaches has advantages and disadvantages, and depending on the characteristics of the oral wound, one product might be preferred over the others.…”
Section: Discussionmentioning
confidence: 99%
“…44,45,54 It is important to note that a similar acute but not sustained inflammation response in oral wounds implanted with collagen-based scaffolds in palatal mucosa has been previously reported. 31,35 Although the mechanisms orchestrating this regulated immune response remain to be elucidated, a recent report suggests that acute and transient infiltration of inflammatory cells promotes the regeneration of mucosal epithelium via IL-11 and IL-22-dependent activation of epithelial STAT3. 55 It would be of great interest to determine if a similar mechanism is operative in the observed AACT and CS regenerative effects.…”
Section: Discussionmentioning
confidence: 99%